CLEC9A and cancer: We propose that beads coupled to F-actin and myosin II, in addition to proving useful for probing DNGR-1 function, may therefore provide an alternative strategy to antibodies for targeting antigens to cross-presenting cDC1 (Caminschi et al., 2012), which could be exploited for vaccination in cancer and other settings.